Last updated on June 2019

Efficacy and Safety of Cannabidiol Oral Solution (GWP42003-P CBD-OS) in Patients With Rett Syndrome

Brief description of study

To evaluate the efficacy of cannabidiol oral solution (GWP42003-P, CBD-OS) in reducing symptom severity when compared with placebo, in patients with Rett syndrome.

Clinical Study Identifier: NCT03848832

Find a site near you

Start Over

Recruitment Status: Open

Brief Description Eligibility Contact Research Team

Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.